298060 — SCM LifeScience Co Balance Sheet
0.000.00%
- KR₩48bn
- KR₩48bn
- KR₩825m
Annual balance sheet for SCM LifeScience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | ARS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 34,171 | 18,890 | 6,916 | 4,496 | 920 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 123 | 125 | 67.6 | 139 | 173 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 36,086 | 20,312 | 10,040 | 13,260 | 1,996 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 11,544 | 11,117 | 10,650 | 10,254 | 20,450 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 76,292 | 54,045 | 33,020 | 25,404 | 23,170 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,259 | 8,709 | 4,562 | 1,148 | 5,741 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 13,213 | 9,432 | 8,509 | 4,930 | 8,991 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 63,079 | 44,613 | 24,511 | 20,474 | 14,179 |
| Total Liabilities & Shareholders' Equity | 76,292 | 54,045 | 33,020 | 25,404 | 23,170 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |